HEAT BIOLOGICS, INC. 4
4 · HEAT BIOLOGICS, INC. · Filed Feb 9, 2017
Insider Transaction Report
Form 4
Rosar Ann A
VP of Finance
Transactions
- Tax Payment
Common Stock
2017-02-07$0.88/sh−6,764$5,936→ 63,236 total
Footnotes (1)
- [F1]The reporting person previously reported the acquisition of 70,000 shares of Heat Biologics, Inc. common stock, $0.0002 par value per share (the "Common Stock"), represented by 70,000 restricted stock units ("RSUs"). The reporting person sold 6,764 shares of Common Stock to satisfy tax obligations. Each RSU represents a contingent right to receive one share of Common Stock. The 70,000 RSUs vest as follows: (i) 17,500 vested on January 2, 2017 (of which 6,764 were sold to satisfy tax obligations and 10,736 remain); (ii) 17,500 will vest on January 2, 2018; (iii) 17,500 will vest on January 2, 2019; and (iv) 17,500 will vest on January 2, 2020, provided that the reporting person is not terminated for cause prior to such dates.